Loading...
Fetching results...
0 items found

A0481: Proclarix aids in resolving indeterminate multi-parametric magnetic resonance imaging for the improved diagnosis of prostate cancer

Speaker
Mrs. M. (Miriam) Campistol Torres
Authors
Campistol Torres M.1, Morote J.1, Pye H.2, Athanasiou A.3, Celma A.1, Regis L.1, Planas J.1, Santamaria A.1, Trilla E.1, Schiess R.3, Punwani S.4, Whitaker H.2, Ahmed H.U.5, Emberton M.6
Institutions
1Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Dept. of Urology, Barcelona, Spain, 2University College London, Molecular Diagnostics and Therapeutics Group, London, United Kingdom, 3Proteomedix AG, Dept. of Research & Development, Zurich-Schlieren, Switzerland, 4University College London, Centre for Medical Imaging, London, United Kingdom, 5Imperial College London, Dept. of Surgery and Cancer, London, United Kingdom, 6University College London, Division of Surgery and Interventional Science, London, United Kingdom
Event
37th Annual EAU Congress
Date – Time - Location
03 July 2022, 10:30 - 12:00, Yellow Area, Room Forum
Session
Abstract Session 26 - PCa localised imaging grade prediction, reporting and markers
Topic
Prostate Cancer, localised - Diagnosis, Markers
  • © 2022 European Association of Urology
  • Disclaimer